focus
Business Development
We, at Rasayani Biologics Pvt Ltd, strive to provide easy to administer, economic and effective therapies for prevention of critical illness
- Business Focus
- Salient Features
- Business Approach
Business Focus
- Organize and implement modern methods of scientific research in “State-of-the-Art” Lab and clinical studies for select promising drugs.
- Drugs are based on the premise of reverse pharmacology reducing the uncertainties in clinical development substantially.
- Patent scientific breakthroughs / achievements.
- Out-license Patented technologies at various stages of development.
- Manufacture products in India and establish marketing tie-ups with major pharma multinationals having a global market presence and reach
Salient Features
- RBPL specializes at synthesizing nano Particles of Noble Metals and Base Elements using Patented platform technology.
- The Metals are converted into bio-compatible & therapeutically effective form using unique green technology process.
- Environment friendly process, involves no use of any harmful chemicals unlike conventional nano material synthesis..
- RBPL’s Nano Technology can be applied in many other applications.
Business Approach
- We are aware that exploring complex therapeutic challenges needs a networking of varied scientific disciplines and a sound financial acumen. We look to partner with the best and brightest in the industry to challenge the conventional drug development, think beyond economics and make a lasting impression on the therapeutic landscape of all critical illnesses.
- The partnership deals can be structured to leverage our unique attributes and the strong points of the partner in the convergent ways to carry forward the drug development with a singular aim of providing eternal-patient centric solutions.
- We strongly believe in building partnerships that create value for everyone involved and is based on unwavering trust as a foundation. We are open to collaborate on the pipeline drugs which are in the different phases of developmental pathways.